DXB

DIMERIX LTD

0.54

0.01+0.93%

Closed16:10 01/09 AEDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.535/0.535

TODAY RANGE0.535-0.555

VOL1.21M

MARKET CAP324.21M

52 WEEK RANGE0.340-0.785

AVG VOL (3M)1.63M

% TURNOVER0.15%

TURNOVER662.96K

P/E (TTM)-22.8814

% RANGE3.74%

EPS(TTM)-0.0236

P/E(FORWARD)-26.2500

P/B24.11

BVPS0.022

DIVIDEND--

P/S54.55

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP246.20M

SHARES OUTSTANDING600.40M

NEXT EARNINGS02/23-02/27

FREE FLOAT455.93M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

ASX·12/23/2025 21:38
Dimerix receives input from FDA on ACTION3 trial endpoints
ASX·12/21/2025 22:18
BioMarin to acquire Dimerix US Partner, Amicus Therapeutics
ASX·12/14/2025 21:47
DMX-200 ACTION3 Phase 3 Trial Completes Recruitment
ASX·12/12/2025 03:52
Change of Director's Interest Notice - CS,HA,NW,SP & MD
ASX·12/12/2025 03:06
Notification regarding unquoted securities - DXB
ASX·11/18/2025 16:07
Successful Completion of Planned IDMC Review
ASX·11/17/2025 23:59
Results of AGM
ASX·11/17/2025 19:59
Chair Address and AGM Presentation
ASX·10/28/2025 21:37
Quarterly Appendix 4C and Activities Report
ASX·10/22/2025 05:22
Cleansing Notice
ASX·10/22/2025 05:16
Application for quotation of securities - DXB
ASX·10/20/2025 21:34
Canaccord Drug & Device Conference Investor Presentation
ASX·10/16/2025 00:00
2025 AGM Notice of Meeting, Letter of Access and Proxy
ASX·10/07/2025 21:39
Successful PARASOL Collaboration Data Analysis Outcome
ASX·09/29/2025 22:39
DMX-200 receives Orphan Drug Designation in Japan

Same Industry

Name/Symbol

Change%

Price

No data yet, let's see others

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.